Nanomedicine (Online) 18 (2019): 371–379. doi:10.1016/j.nano.2018.11.001 info:cnr-pdr/source/autori:Pellegrino M. (a); Ceccacci F. (b); Petrini S. (c); Scipioni A. (d); De Santis S. (d); Cappa M. (e); Mancini G. (f); Fierabracci A. (a)/titolo:Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes/doi:10.1016%2Fj.nano.2018.11.001/rivista:Nanomedicine (Online)/anno:2019/pagina_da:371/pagina_a:379/intervallo_pagine:371–379/volume:18